AI assistant
Sending…
SYNOPSYS INC — Director's Dealing 2021
Mar 25, 2021
29855_dirs_2021-03-25_2629d62d-895a-4a65-adbf-511f28551702.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2021-03-24
Reporting Person: RUNKEL JOHN F JR (GC & Corporate Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-24 | Common Stock | M | 1571 | $135.88 | Acquired | 21725 | Direct |
| 2021-03-24 | Common Stock | S | 1571 | $238.0 | Disposed | 20154 | Direct |
| 2021-03-24 | Common Stock | M | 1322 | $89.76 | Acquired | 21476 | Direct |
| 2021-03-24 | Common Stock | S | 1322 | $238.0 | Disposed | 20154 | Direct |
| 2021-03-24 | Common Stock | M | 1343 | $90.51 | Acquired | 21497 | Direct |
| 2021-03-24 | Common Stock | S | 1343 | $238.0 | Disposed | 20154 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-24 | Non-Qualified Stock Option (right to buy) | $89.76 | M | 1322 | Disposed | 2025-12-12 | Common Stock (1322) | Direct |
| 2021-03-24 | Non-Qualified Stock Option (right to buy) | $90.51 | M | 1343 | Disposed | 2024-12-08 | Common Stock (1343) | Direct |
| 2021-03-24 | Non-Qualified Stock Option (right to buy) | $135.88 | M | 1571 | Disposed | 2026-12-12 | Common Stock (1571) | Direct |
Footnotes
F1: 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
More from SYNOPSYS INC
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2